Deals
Danaher Ditches Industrial Roots as Pall Seals Health-Care March
Inside Danaher’s Decision to Buy Pall for $13.8B
This article is for subscribers only.
Danaher Corp.’s purchase of Pall Corp. for $13.8 billion will complete a march toward becoming a provider of health-care instruments and services and away from its roots as a manufacturer started by the billionaire Rales brothers.
Danaher will absorb Pall, a maker of biopharma and medical products, and split off its industrial businesses into a company with $6 billion of annual sales. Danaher, which will retain its current top management, will be a “science and technology growth company” with revenue of $16.5 billion.